Point-of-Care Testing
News on technologies and applications for point-of-care testing.
The assay detects HPV 16 and HPV 18 DNA within 45 minutes and is intended to be used in low-resource settings.
In particular, Black veterans seen through an on-site program at a Philadelphia VA medical center were nearly five times more likely to get tested than through a telemedicine consult.
Domus Diagnostics Wins $2.4M NIH RADx Tech Contract
The firm will use the funding to validate a rapid, low-cost, zero-power multiplex assay for COVID-19, flu A and B, and respiratory syncytial virus.
AmplifiDx Gets $1.4M NIH RADx Grant for Point-of-Care Molecular Testing Instrument
The Massachusetts-based firm plans to use the funding toward development of its nucleic acid amplification test platform and multiplex respiratory test.
The startup is looking to close a $9 million Series A round in Q3 and launch the system and a strep A assay in 2024.